Study guide

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support

Key Takeaways Explain This Topic AI

Identify an implanted device by its route, anatomic endpoints, and characteristic components, then corroborate device type and settings from the chart, radiograph, interrogation, or operative record.

For transvenous leads, document chamber course, tricuspid interaction, regurgitation, masses, myocardial penetration, pericardial fluid, and right-heart response without calling infection or perforation from one uncertain image.

For occluders and closure devices, assess seating, stability, residual flow, surrounding-valve or vessel interaction, obstruction, thrombus-like material, and pericardial effusion in multiple views.

Mechanical-support studies require device-specific landmarks plus ventricular unloading, septal position, RV function, valve behavior, cannula or graft flow, speed/settings, prior baseline, and prompt escalation of instability or suspected displacement.

SA-to-AV-to-His-Purkinje activation, AF/flutter and AV-block behavior, ectopic beat effects, bundle delay, and RV/CRT pacing patterns must guide beat selection and mechanical interpretation; echo cannot establish capture or programming by appearance alone.

Last updated: July 2026

Recognize the route before naming the hardware

CCI task D12 is to recognize implanted devices such as ICDs, pacemakers, LAA occluders, closure devices, and mechanical support. Start with the access route and endpoints. A transvenous RA lead often curves into the appendage; an RV lead crosses the tricuspid valve toward the apex or septum. A CRT coronary-sinus lead courses posteriorly in a coronary vein rather than entering the LV cavity. An ICD lead usually has one or more thick echogenic shock coils. Subcutaneous or leadless systems have different appearances, and echo cannot reliably identify manufacturer, programming, battery status, or electrical performance. Reconcile the image with device records, interrogation, and chest radiography.

Device class Anatomic clue Echo questions

Pacemaker/ICD/CRT Intracardiac lead, shock coil, or coronary-sinus course Position, TV interaction, TR, mass, perforation, effusion, chamber response

ASD/PFO occluder Paired discs apposed to atrial septum Seating, septal tissue capture, residual shunt, erosion, obstruction

LAA occluder Device at LAA ostium Position, peri-device flow, device-related mass, effusion

Durable LVAD LV apical inflow and ascending-aortic outflow graft Unloading, septum, RV, valves, cannula/graft flow, complications

Temporary MCS Device-specific cannula, pump, or balloon route Model-specific depth, inflow/outflow, unloading, vascular/chamber effects

Use electrophysiology to interpret timing and devices

Electrical activation precedes and organizes mechanical motion. The sinoatrial node initiates atrial depolarization, represented broadly by the P wave. Conduction slows through the AV node, allowing ventricular filling, then travels through the His bundle, right and left bundle branches, and Purkinje network to produce a coordinated QRS and ventricular contraction. ECG timing is a reference, not a substitute for visible valve events: conduction delay, pacing, preexcitation, and electromechanical delay can shift aortic or mitral closure relative to automated markers.

Rhythm changes both acquisition and physiology. Atrial fibrillation removes consistent organized atrial contraction and creates variable R-R intervals, so Doppler and chamber measurements require representative cycles rather than the first convenient beat. Atrial flutter may have regular atrial activity with fixed or variable AV conduction. AV block can dissociate atrial and ventricular timing. Premature beats change filling, contractility, and the following postectopic beat; neither beat should be used as an ordinary baseline measurement. Bundle-branch delay and ventricular ectopy can create abnormal septal timing that resembles regional dysfunction if ECG and multi-view motion are ignored.

RV myocardial or apical pacing activates the ventricles outside the normal His-Purkinje sequence and may produce a left-bundle-branch-like pattern, early septal motion, delayed lateral contraction, and mechanical dyssynchrony. CRT adds an LV lead, usually through the coronary sinus, to improve activation coordination in selected patients, but echo appearance alone cannot prove electrical capture, sensing, battery state, or optimal programming. Correlate ECG morphology and rhythm with interrogation. During echo, document the paced or intrinsic rhythm, choose comparable beats, interpret septal motion in that context, and reserve programming changes for the electrophysiology/device team.

Examine leads and closure devices systematically

Follow every visible lead in two planes. At the tricuspid valve, look for leaflet impingement, adherence, entanglement, perforation, restricted coaptation, and the origin and severity of TR. Compare RV and RA size/function and estimate pressure when valid. A mobile lead-associated echodensity may represent fibrin, thrombus, vegetation, redundant lead, or artifact. Describe size, attachment, mobility, and image quality; fever, cultures, pocket findings, embolic events, TEE, and sometimes CT or metabolic imaging establish the clinical diagnosis. Do not call endocarditis from an incidental strand or exclude it because TTE is negative.

A lead tip apparently beyond myocardium should be confirmed in orthogonal views with altered gain and depth. New chest pain, capture failure, hypotension, or pericardial fluid makes perforation more concerning. Immediately communicate a convincing extracardiac course, enlarging effusion, chamber collapse, or deterioration. Echo shows the anatomic and hemodynamic findings; electrophysiology and clinical teams integrate interrogation and cross-sectional imaging and decide management.

An ASD/PFO occluder commonly appears as two discs straddling the atrial septum. Show that both discs are apposed, septal tissue lies between them, and the device does not distort the aortic root, pulmonary veins, coronary sinus, or AV valves. Sweep low-Nyquist color across the full circumference for residual shunt and state its location and direction. A small early residual jet may evolve, so compare with timing and prior studies. Device instability, embolization, new obstruction, pericardial effusion, or suspected erosion is urgent. Failure to see a complication on limited TTE does not replace TEE, ICE, CT, or fluoroscopy when concern persists.

LAA occluders are often incompletely assessed by TTE. TEE or CT more reliably shows device compression, depth, peri-device flow, device-related thrombus, and adjacent pulmonary-vein or mitral interaction. Describe an echogenic surface mass as suspected material until artifact and normal device components are excluded. Other closure devices at a VSD, PDA, paravalvular leak, or access site must be localized to the treated defect; use color to test residual flow and CW only after the jet's origin is established.

Map mechanical support and its hemodynamic effect

A durable continuous-flow LVAD usually drains through an LV apical inflow cannula directed toward mitral inflow and returns blood through an outflow graft to the ascending aorta. Record device type, speed, estimated flow and power shown on the controller, blood pressure, rhythm, and symptoms. Assess LV size and unloading, septal position, RV size/function, IVC, MR/TR, aortic-valve opening frequency, AR, thrombus-like material, and pericardial fluid. Use color and spectral Doppler along inflow and accessible outflow segments, comparing velocity and waveform with device-specific expectations and the patient's baseline. One high velocity does not prove obstruction if angle, aliasing, graft curvature, speed, and loading are unknown.

A very small LV with leftward septal shift, intermittent inflow disturbance, or ventricular ectopy can accompany excessive unloading or a suction event; underfilling, RV failure, tamponade, or cannula malposition may contribute. A dilating LV, more frequent aortic-valve opening, worsening MR, abnormal cannula flow, or rising device power may suggest inadequate support or obstruction, but echo alone does not diagnose pump thrombosis. Search for progressive AR, RV failure, inflow/outflow obstruction, infection-related collections, and intracardiac thrombus. Speed changes belong to the authorized LVAD team during a standardized ramp protocol.

Temporary devices are recognized by route. An axial-flow transaortic pump crosses the aortic valve with an LV inlet and an aortic outlet; its depth and orientation are model specific. TandemHeart drains the LA through a transseptal cannula and returns flow arterially. VA-ECMO drains systemic venous blood and returns it to the arterial circulation; assess LV distention, aortic-valve opening, stasis, RV/LV function, cannula position when visible, and pericardial complications. An IABP lies in the descending aorta and inflates in diastole, then deflates before systole. For every device, label what is actually seen, compare with the prescribed configuration, and urgently escalate migration, perforation, tamponade, severe valve injury, absent expected flow, marked chamber distention, or shock.